Acute pyelonephritis in adults - Prediction of mortality and failure of treatment

被引:80
作者
Efstathiou, SP
Pefanis, AV
Tsioulos, DI
Zacharos, ID
Tsiakou, AG
Mitromaras, AG
Mastorantonakis, SE
Kanavaki, SN
Mountokalakis, TD
机构
[1] Univ Athens, Sch Med, Dept Med 3, Sotiria Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Clin Microbiol Lab, Sotiria Gen Hosp, GR-11527 Athens, Greece
关键词
D O I
10.1001/archinte.163.10.1206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To formulate a classification tool for early recognition of patients admitted with acute pyelonephritis (AP) who are at high risk for failure of treatment or for death. Methods: A retrospective chart review of 225 patients (102 men) admitted with AP. We considered 13 potential risk factors in a multivariate analysis. Results: Recent hospitalization, previous use of antibiotics, and immunosuppression were found to be independent correlates of the prevalence of resistant pathogens in both sexes. Additional predictors included nephrolithiasis in women and a history of recurrent AP in men. Prolonged hospitalization should be expected for a man with diabetes and long-term catheterization who is older than 65 years or for a woman of any age with the same characteristics, when the initial treatment was changed according to the results of urine culture. For mortality prediction, we derived an integer-based scoring system with 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for previous antibiotic treatment for men and 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for immunosuppression for women. Among patients with at least 11 points, the risk for in-hospital death was 100% for men and 91% for women. Conclusions: Simple variables available at presentation can be used for risk stratification of patients with AP. The additional identification of certain risk factors by means of a carefully obtained history could contribute to early recognition of patients infected by resistant bacteria and optimize the selection of antimicrobial agents.
引用
收藏
页码:1206 / 1212
页数:7
相关论文
共 48 条
[21]   TOWARD IMPROVED EMPIRIC MANAGEMENT OF MODERATE TO SEVERE URINARY-TRACT INFECTIONS [J].
LEIBOVICI, L ;
GREENSHTAIN, S ;
COHEN, O ;
WYSENBEEK, AJ .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (12) :2481-2486
[23]   Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8 [J].
Magee, JT ;
Pritchard, EL ;
Fitzgerald, KA ;
Dunstan, FDJ ;
Howard, AJ .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7219) :1239-1240
[24]  
*NAT COMM CLIN LAB, 1993, PERF STAND ANT DISK
[25]   Urinary tract pathogens in complicated infection and in elderly individuals [J].
Nicolle, LE .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 :S5-S8
[26]  
Pak C Y, 1997, Curr Ther Endocrinol Metab, V6, P572
[27]   Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia [J].
Pedersen, G ;
Schonheyder, HC ;
Steffensen, FH ;
Sorensen, HT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :119-126
[28]  
Proca E, 1992, Acta Urol Belg, V60, P41
[29]  
ROBERTS FJ, 1991, REV INFECT DIS, V13, P34
[30]  
ROBERTS JA, 1981, INVEST UROL, V19, P148